Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - Proteomics, metabolomics and single cell proteomics of cells treated with KRASG12D inhibitor MRTX1133

ABSTRACT: The metabolomics data from a multiomics study of the cellular response to a KRASG12D inhibitor, MRTX1133. This repository will accompany the completed bulk pasedDIA analysis of cells treated with inhibitor and approximately 3,000 single cells treated with the same dose and conditions.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Benjamin C Orsburn

PROVIDER: MSV000091110 | GNPS | Sun Jan 22 05:09:00 GMT 2023

SECONDARY ACCESSION(S): PXD039597

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Proteomics, metabolomics and single cell proteomics of cells treated with KRASG12D inhibitor MRTX1133

Project description:The metabolomics data from a multiomics study of the cellular response to a KRASG12D inhibitor, MRTX1133. This repository will accompany the completed bulk pasedDIA analysis of cells treated with inhibitor and approximately 3,000 single cells treated with the same dose and conditions.

2023-01-22 | MSV000091110 | MassIVE

Bulk RNA-seq of human cortical organoids treated with GSK3 inhibitor CHIR99021

Project description:Bulk RNA-seq of human cortical organoids treated with GSK3 inhibitor CHIR99021

| PRJEB38729 | ENA

Expression data in LoVo cells treated with MEK inhibitor

Project description:Expression data in LoVo cells treated with MEK inhibitor

| PRJNA422292 | ENA

RNAseq data on single dose KMO inhibitor (CHDI-00340246) treated R6/2 mice.

Project description:RNAseq data on single dose KMO inhibitor (CHDI-00340246) treated R6/2 mice.

| PRJNA415795 | ENA

Regulation of gene expression in ALK inhibitor CH5424802-treated NCI-H2228 xenograft tumors

Project description:To clarify the downstream signal pathway of EML4-ALK in NSCLC, we performed Affymetrix GeneChip analysis using ALK inhibitor CH5424802-treated NCI-H2228 xenograft tumors, and comprehensively characterized the gene expression regulated by inhibition of activated ALK. Mice bearing NCI-H2228 cells were orally administered at dose of 0 (vehicle), 4 or 20 mg/kg of CH5424802, and the tumors were collected and lysed at 6 hours post-dose. Total RNA were extracted from xenograft tumors.

2011-06-03 | E-GEOD-25118 | biostudies-arrayexpress

Analysis of MV4;11 cells treated with ASH1L inhibitor AS-99

Project description:Analysis of MV4;11 cells treated with ASH1L inhibitor AS-99

| PRJNA631052 | ENA

Transcriptome of MV4;11 cells treated with ASH1L inhibitor AS-99

Project description:Transcriptome of MV4;11 cells treated with ASH1L inhibitor AS-99

| PRJNA631053 | ENA

Expression profiling in Prostate cancer cells treated with DOT1L inhibitor

Project description:Expression profiling in Prostate cancer cells treated with DOT1L inhibitor

| PRJNA559347 | ENA

MCF-7 cells treated with p300 KAT inhibitor A-485

Project description:MCF-7 cells treated with p300 KAT inhibitor A-485